XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Summary of Stock Option Activity (Details) - Equity Option - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Number of Shares, Beginning Balance 2,736,918  
Granted, Number of Shares 3,485,500  
Forfeited, Number of Shares (8,000)  
Exercised, Number of Shares 0  
Expired, Number of Shares 0  
Number of Shares, Ending Balance 6,214,418 2,736,918
Vested and expected to vest, Number of Shares 6,214,418  
Exercisable, Number of Shares 929,919  
Outstanding, Beginning Balance, Weighted-Average Exercise Price per Share $ 13.82  
Granted, Weighted-Average Exercise Price per Share 3.84  
Forfeited, Weighted-Average Exercise Price per Share 3.72  
Exercised, Weighted-Average Exercise Price per Share 0  
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 0  
Outstanding, Ending Balance, Weighted-Average Exercise Price per Share | $ / shares 8.24 $ 13.82
Vested and expected to vest, Weighted-Average Exercise Price per Share 8.24  
Exercisable Weighted-Average Exercise Price per Share $ 18.25  
Outstanding, Weighted-Average Remaining Contractual Term (years) 9 years 3 months 18 days 8 years 9 months 25 days
Vested and expected to vest, Weighted-Average Remaining Contractual Term (years) 9 years 3 months 18 days  
Exercisable, Weighted-Average Remaining Contractual Term (years) 8 years 3 months 10 days  
Outstanding, Aggregate Intrinsic Value $ 37,544 $ 3,636,148
Vested and expected to vest, Aggregate Intrinsic Value 37,544  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value $ 0